about us
We are the
4th largest Pharma
company in India.
4th largest Pharma
company in India.
At Mankind, we believe that we are participating in the accelerated change in the heart of India through our core values of Affordability, Quality and Accessibility backed by our strong in-house manufacturing and R&D capabilities.
LEADERSHIP
Meet our leadership team

View Full Bio 
Mr. Ramesh Juneja
Chairman & Whole-Time Director

Mr. Ramesh Juneja
Chairman & Whole-Time Director
Mr. Ramesh Juneja, a visionary leader with over 33 years of experience in the pharmaceutical industry. Under his forward-thinking leadership, Mankind Pharma transformed from a small venture into a billion-dollar generics giant, making affordable medicines accessible across India. He co-founded the company in 1995 with his brother, Rajeev Juneja, championing low-cost generics as a core ethos. His commitment to quality and transparency has earned him prestigious awards, including ‘Entrepreneur of the Year’ 2023 by Economic Times. Beyond business, he prioritizes ethical business practices and employee well-being, fostering a culture of integrity at Mankind Pharma. Mr. Juneja envisions a ‘Healthier Bharat’ in the future where every Indian has access to quality and affordable medication.

View Full Bio 
Mr. PK Arora
Director - FHA

Mr. PK Arora
Director - FHA
Mr. Prem Kumar Arora, co-founded Mankind Pharma alongside Ramesh and Rajeev Juneja. He has been instrumental in shaping the company’s growth and strategic direction, helping Mankind Pharma emerge as the fourth-largest pharmaceutical company in India by domestic sales. Overseeing finance, HR, and operations, he ensures affordability, quality, and accessibility remain at the company’s core. His strategic vision has expanded Mankind Pharma’s reach to over 30+ countries. Beyond Mankind Pharma, he holds directorships in 15 companies across real estate, hospitality, and healthcare, including Pathkind Diagnostics. His leadership continues to drive Mankind Pharma’s mission of delivering cost-effective healthcare globally.

View Full Bio 
Mr. Rajeev Juneja
Managing Director & Vice Chairman

Mr. Rajeev Juneja is a first-generation entrepreneur who co-founded Mankind Pharma in 1995 with his brother, Ramesh Juneja, after gaining deep market insights. His visionary leadership has positioned Mankind among India’s top pharmaceutical companies. Known for his innovative and customer-centric approach, he has driven Mankind Pharma’s expansion into OTC and super speciality segments while fostering a strong culture of teamwork and agility. A believer in continuous learning, he nurtures talent and champions ground-breaking ideas to ensure sustainable growth. His efforts have earned him accolades, including the “Entrepreneur of the Year” 2023 by Economic Times.

View Full Bio 
Mr. Sheetal Arora
CEO & Whole-Time Director

Mr Sheetal Arora is a trailblazing leader driving the company’s operations, global expansion and innovation. With over 25 years of experience, he has played a pivotal role in launching specialty divisions and managing emerging markets. His expertise spans sales, marketing, and field force management across domestic and international markets. Under his leadership, Mankind Pharma has expanded into new divisions like Lifestar Pharma and Star Mankind. Mr. Arora also has diverse experience across ROW countries and emerging markets. One of his strongest assets is his ability to excel within diverse socio-cultural environments.

View Full Bio 
Mr. Arjun Juneja
Chief Operating Officer

Mr. Arjun Juneja has been instrumental in driving innovation, operational excellence, and global expansion at Mankind Pharma. Since joining in 2009, he has overseen R&D, manufacturing, supply chain, and IT, leading Mankind’s successful IPO in 2023. He spearheaded Mankind Pharma’s entry into the US market and secured USFDA approvals for regulated markets. Under his leadership, state-of-the-art R&D centers in Manesar were established, fostering pharmaceutical advancements. He also transformed Mankind Pharma from a family-run business into a professionally managed institution while overseeing strategic investments through the Mankind Family Office. Recognized among India’s top young business leaders, he serves as Chairman of FICCI’s Pharma Committee.
our mission
To be able to provide cost-effective, innovation based superior quality pharmaceutical products that improve the lives of the patients.
our vision
To be an innovative and research focused healthcare company, most admired for its Quality, Affordability and Accessibility.
25+
Countries
1000+
Approved Products
29 Years
of Pharmaceutical Excellence
A story of transformation
and resilience
and resilience
With over two decades of excellence, Mankind Pharma is now among India's top 5 pharmaceutical companies, powered by a 21,000+ strong workforce.

GLOBAL PRESENCE
Leaving footprints
all over the world.
all over the world.
Mankind aspires to be customer-centric and a leader in the Global markets. Committed towards a healthier and happier world, we strive to provide accessible and affordable healthcare to all sections of the society. Today, Mankind operates in 34 countries
across the Globe.
OUR INTERNATIONAL BUSINESS
GLOBAL MARKETS
MANUFACTURING UNITS
R&D CENTERS
Europe
Discover how Mankind Pharma is making a difference in healthcare across established and emerging markets.
- UK
- Spain
- France
- Netherlands
- Belgium
- Germany
- Italy
- Poland
- Romania
LATAM
Discover how Mankind Pharma is making a difference in healthcare across established and emerging markets.
- Brazil
- Chile
- Mexico
- Panama
- Guatemala
- Panama
- Peru
Africa
Discover how Mankind Pharma is making a difference in healthcare across established and emerging markets.
- Uganda
- Zambia
- Kenya
- Tanzania
- South Africa
MENA
Discover how Mankind Pharma is making a difference in healthcare across established and emerging markets.
- Ukraine
- Afghanistan
- Algeria
- Morocco
- Iraq
- Oman
- UAE
- Yemen
China
Discover how Mankind Pharma is making a difference in healthcare across established and emerging markets.
- China
Russia
Discover how Mankind Pharma is making a difference in healthcare across established and emerging markets.
- Russia
ASEAN
Discover how Mankind Pharma is making a difference in healthcare across established and emerging markets.
- Nepal
- Sri Lanka
- Bangladesh
- Myanmar
- Malaysia
- Philippines
- Thailand
- Cambodia
- Australia
CIS
Discover how Mankind Pharma is making a difference in healthcare across established and emerging markets.
- Kazakhstan
- Uzbekistan
North America
Discover how Mankind Pharma is making a difference in healthcare across established and emerging markets.
- United States of America
Manufacturing Unit I
No.of sites
01
Capacity
194 Million units
Certifications
NPRA, SMDC, PPB, NDA, FMHACA, TMDA, NAFDAC, etc.
Manufacturing Unit II
No.of sites
01
Capacity
1.38 Billion units
Certifications
NPRA, SMDC, PPB, NDA, FMHACA, TMDA, etc.
Manufacturing Unit III
No.of sites
01
Capacity
1.24 Billion units
Certifications
USFDA, UAE,SMDC, etc.
Mankind Agritech Pvt. Ltd.
No.of sites
01
Capacity
2.24 Billion units
Certifications
--
Mankind Medicare Pvt. Ltd.
No.of sites
01
Capacity
--
Certifications
--
Qualitek Starch Pvt. Ltd.
No.of sites
01
Capacity
--
Certifications
FDA
Mankind Pharma Ltd.
No.of sites
01
Capacity
363 Million units
Certifications
--
Shree Jee Laboratory Pvt. Ltd.
No.of sites
01
Capacity
166 Million units
Certifications
USFDA, KFDS,MHRA,WHO-GMP, ISO
Mankind Pharma Ltd.
No.of sites
01
Capacity
8.4 Billion units
Certifications
--
LifeStar Pharmaceuticals Pvt. Ltd.
No.of sites
01
Capacity
30.6 Million units
Certifications
--
MRC-01
R&D Focus
Development of Inhalation dosage forms, like Dry Powder Inhaler, Metered Dose Inhaler, Soft Mist Inhaler, Nasal Sprays, Nebulizing Solutions.
Certifications
DSIR approved
MRC-02
R&D Focus
Under revamping with total area ~1.7 Lacs Sq. ft. built-up area to create pharmaceutical research facility with global standards.
Certifications
--
MRC-03
R&D Focus
Development of ophthalmic & Injectable formulations along with analytical research and method validation lab. Scale up facility of API & Oral solid dosage forms.
Certifications
Scale up facilities are cGMP & state FDA approved.
Analytical method validation labs are USFDA approved.
Mankind Inhalation R&D Center
No.of sites
03
Capacity
1.38 Billion units
R&D Focus
Dedicated for development of Inhalation dosage forms. Inhalation Dosage forms – Dry Powder Inhaler, Metered Dose Inhaler, Soft Mist Inhaler, Nasal Sprays, Nebulizing Solutions.
Mankind Inhalation R&D Center
R&D Focus
Development of Inhalation dosage forms, like Dry Powder Inhaler, Metered Dose Inhaler, Soft Mist Inhaler, Nasal Sprays, Nebulizing Solutions.
Certifications
--
Mediforce Research Pvt. Ltd.
R&D Focus
For Cosmetics and Formulations process and analytical research and development activities.
Certifications
NABL accredited and GLP (Good lab practices) certified
COPMED Pharamacueticals Pvt. Ltd.
R&D Focus
Development of Simple to complex Oral Solid dosage forms which includes tablets, capsules, dry powders etc.
Certifications
--
BRAND INITIATIVES
We go the extra mile
for every citizen
for every citizen
AWARDS & RECOGNITION
Celebrated
as visionaries
as visionaries
Mankind Pharma is proud to be recognized with multiple awards for advancements in research and development, excellence in manufacturing, dedication to quality, and fostering a supportive working environment.

Know more about us